We are live on ! Find out more
QC

Quadrature Capital Portfolio holdings

AUM $11.7B
1-Year Est. Return 87.29%
This Fund
S&P 500
This Quarter Est. Return
+5.32%
1 Year Est. Return
+87.29%
3 Year Est. Return
+211.84%
5 Year Est. Return
+162.22%
10 Year Est. Return
+656.25%
AUM
$9.8B
AUM Growth
+$1.34B
Cap. Flow
+$1.32B
Cap. Flow %
13.46%
Top 10 Hldgs %
22.18%
Holding
1,749
New
756
Increased
260
Reduced
198
Closed
532

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$299M
2
MSTR icon
Strategy Inc
MSTR
+$174M
3
NOW icon
ServiceNow
NOW
+$152M
4
AMD icon
Advanced Micro Devices
AMD
+$149M
5
TSM icon
TSMC
TSM
+$145M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$282M
2
RY icon
Royal Bank of Canada
RY
+$265M
3
HOOD icon
Robinhood
HOOD
+$258M
4
PLTR icon
Palantir
PLTR
+$194M
5
AAPL icon
Apple
AAPL
+$164M

Sector Composition

Rank Sector Weight
1 Technology 24.12%
2 Consumer Discretionary 12.45%
3 Industrials 11.48%
4 Financials 10.67%
5 Healthcare 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTM icon
976
Castellum
CTM
$57.8M
$196K ﹤0.01%
217,471
+161,752
+290% +$173K
ATAI icon
977
AtaiBeckley Inc
ATAI
$2.68B
$196K ﹤0.01%
+47,848
New +$226K
FINV
978
FinVolution Group
FINV
$1.11B
$194K ﹤0.01%
+37,185
New +$218K
OCGN icon
979
Ocugen
OCGN
$444M
$194K ﹤0.01%
143,929
-307,653
-68% -$438K
SPIR icon
980
Spire Global
SPIR
$543M
$193K ﹤0.01%
+25,777
New +$252K
GBDC icon
981
Golub Capital BDC
GBDC
$3.41B
$193K ﹤0.01%
+14,239
New +$197K
NRIX icon
982
Nurix Therapeutics
NRIX
$2.69B
$193K ﹤0.01%
+10,172
New +$146K
NIO icon
983
NIO
NIO
$12.1B
$192K ﹤0.01%
37,611
-7,619,390
-100% -$47M
ZURA icon
984
Zura Bio
ZURA
$535M
$192K ﹤0.01%
+36,572
New +$145K
VNCE icon
985
Vince Holding Corp
VNCE
$83.4M
$191K ﹤0.01%
+46,734
New +$143K
RFIL icon
986
RF Industries
RFIL
$135M
$190K ﹤0.01%
+32,938
New +$228K
TDOC icon
987
Teladoc Health
TDOC
$1.29B
$189K ﹤0.01%
27,065
-2,755
-9% -$21.6K
MF
988
MindForge Inc. Class A Ordinary Shares
MF
$18.5M
$189K ﹤0.01%
3,820
-1,395
-27% -$71.9K
DMAC icon
989
DiaMedica Therapeutics
DMAC
$358M
$188K ﹤0.01%
+23,572
New +$176K
AMLX icon
990
Amylyx Pharmaceuticals
AMLX
$2.53B
$187K ﹤0.01%
15,465
-12,821
-45% -$174K
BULL
991
Webull Corp
BULL
$3.86B
$186K ﹤0.01%
23,995
-472,016
-95% -$4.75M
ZNTL icon
992
Zentalis Pharmaceuticals
ZNTL
$297M
$186K ﹤0.01%
137,568
+76,917
+127% +$112K
ORC
993
Orchid Island Capital
ORC
$1.3B
$186K ﹤0.01%
+25,775
New +$188K
PRME icon
994
Prime Medicine
PRME
$571M
$183K ﹤0.01%
52,866
+42,684
+419% +$190K
BTE icon
995
Baytex Energy
BTE
$3.06B
$182K ﹤0.01%
56,403
-2,798,797
-98% -$7.8M
DDI
996
DoubleDown Interactive
DDI
$597M
$180K ﹤0.01%
+20,863
New +$187K
BHK icon
997
BlackRock Core Bond Trust
BHK
$664M
$180K ﹤0.01%
18,762
+6,228
+50% +$60.4K
FBIO icon
998
Fortress Biotech
FBIO
$91.4M
$180K ﹤0.01%
+49,096
New +$140K
CC icon
999
Chemours
CC
$2.2B
$175K ﹤0.01%
+14,860
New +$191K
SRFM icon
1000
Surf Air Mobility
SRFM
$94.4M
$175K ﹤0.01%
90,015
+16,593
+23% +$53.1K
38 39
40
41 42

Similar funds

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return
PI
PineBridge Investments New York $11.9B AUM 23.42% 1-Year Est. Return
UE
Unisphere Establishment Vaduz, Liechtenstein $11.9B AUM 6.1% 1-Year Est. Return
LC
Loews Corp New York $11.9B AUM 8.99% 1-Year Est. Return
DWM
Dynasty Wealth Management St. Petersburg, Florida $11.5B AUM 15.23% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Quadrature Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrature Capital held 1,749 positions worth $9.8B, up 16% from $8.45B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Quadrature Capital deployed $1.32B of net new capital in Q4 2025, opening 756 new positions and adding to 260 existing holdings. Its largest new stake was UnitedHealth: 882,161 shares worth $291M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Royal Bank of Canada, an estimated $265M trimmed.

  • Quadrature Capital's largest Q4 2025 buy was UnitedHealth: 882,161 shares worth $291M.
  • Quadrature Capital added most to Advanced Micro Devices in Q4 2025, an estimated $149M increase.
  • Quadrature Capital's biggest Q4 2025 reduction was Royal Bank of Canada, cutting an estimated $265M.
  • Quadrature Capital fully exited NVIDIA in Q4 2025, selling an estimated $282M.
  • Quadrature Capital's ten largest holdings make up 22% of its $9.8B portfolio in Q4 2025.
  • Quadrature Capital opened 756 new positions and closed 532 in Q4 2025.
  • Quadrature Capital's portfolio value rose 16% quarter-over-quarter to $9.8B.

Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.